Income Statement (TTM)
HLS Therapeutics Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54 | 56 | 57 | 59 | 61 | 60 | 60 | 61 | 61 | 61 | 62 | 63 | 63 | 63 | 61 | 59 | 57 | 57 | 57 | 56 |
| Change (%) | 4.76 | 0.76 | 4.14 | 3.28 | -1.31 | 0.40 | 0.97 | 1.06 | -0.02 | 0.33 | 1.44 | 0.53 | 0.30 | -3.62 | -3.12 | -3.31 | -0.56 | 0.26 | -0.61 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 14 | 14 | 15 | 15 | 16 |
| Change (%) | 6.95 | 0.46 | 0.30 | 4.97 | 0.36 | 1.26 | 1.06 | 3.42 | 4.83 | 2.72 | 6.48 | 5.89 | 6.42 | 3.93 | 3.71 | 0.91 | 2.12 | 5.42 | 0.96 | |
| % of Revenue | 15.87 | 16.20 | 16.16 | 15.56 | 15.81 | 16.08 | 16.22 | 16.23 | 16.61 | 17.42 | 17.84 | 18.72 | 19.72 | 20.92 | 22.56 | 24.16 | 25.21 | 25.89 | 27.22 | 27.65 |
| Gross Operating Profit | 45 | 47 | 47 | 50 | 51 | 50 | 50 | 51 | 51 | 51 | 51 | 51 | 50 | 50 | 47 | 45 | 43 | 42 | 41 | 41 |
| Change (%) | 4.34 | 0.81 | 4.88 | 2.97 | -1.62 | 0.24 | 0.96 | 0.60 | -0.99 | -0.18 | 0.34 | -0.70 | -1.20 | -5.62 | -5.11 | -4.66 | -1.47 | -1.54 | -1.20 | |
| % of Revenue | 84.13 | 83.80 | 83.84 | 84.44 | 84.19 | 83.92 | 83.78 | 83.77 | 83.39 | 82.58 | 82.16 | 81.28 | 80.28 | 79.08 | 77.44 | 75.84 | 74.79 | 74.11 | 72.78 | 72.35 |
| SG&A | 25 | 26 | 28 | 27 | 27 | 26 | 25 | 28 | 29 | 30 | 30 | 30 | 30 | 28 | 28 | 27 | 27 | 27 | 26 | 24 |
| Change (%) | 5.50 | 8.85 | -2.70 | -1.45 | -2.50 | -4.02 | 9.97 | 5.21 | 1.91 | 0.93 | -0.89 | 1.30 | -6.49 | -0.42 | -3.09 | -2.01 | 0.68 | -5.06 | -5.36 | |
| % of Revenue | 45.87 | 46.19 | 49.90 | 46.63 | 44.49 | 43.96 | 42.02 | 45.77 | 47.65 | 48.57 | 48.86 | 47.74 | 48.10 | 44.85 | 46.33 | 46.35 | 46.97 | 47.56 | 45.03 | 42.88 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 65 | 68 | 69 | 68 | 68 | 66 | 66 | 70 | 73 | 75 | 75 | 76 | 76 | 73 | 71 | 69 | 65 | 64 | 63 | 62 |
| Change (%) | 5.09 | 1.68 | -2.09 | 0.76 | -3.08 | 0.12 | 5.48 | 4.64 | 2.32 | 0.67 | 0.43 | 0.59 | -3.69 | -2.73 | -4.02 | -4.55 | -1.72 | -1.75 | -2.52 | |
| % of Revenue | 121.16 | 121.54 | 122.65 | 115.31 | 112.50 | 110.47 | 110.16 | 115.08 | 119.16 | 121.96 | 122.37 | 121.15 | 121.23 | 116.41 | 117.49 | 116.40 | 114.91 | 113.57 | 111.29 | 109.15 |
| Operating Income | -11 | -12 | -13 | -9 | -8 | -6 | -6 | -9 | -12 | -13 | -14 | -13 | -13 | -10 | -11 | -10 | -8 | -8 | -6 | -5 |
| Change (%) | 6.65 | 5.96 | -29.61 | -15.72 | -17.29 | -2.55 | 49.82 | 28.41 | 14.56 | 2.22 | -4.08 | 0.88 | -22.48 | 2.73 | -9.15 | -12.08 | -9.49 | -16.61 | -19.46 | |
| % of Revenue | -21.16 | -21.54 | -22.65 | -15.31 | -12.50 | -10.47 | -10.16 | -15.08 | -19.16 | -21.96 | -22.37 | -21.15 | -21.23 | -16.41 | -17.49 | -16.40 | -14.91 | -13.57 | -11.29 | -9.15 |
| Interest Expense | -6 | -6 | -6 | -7 | -7 | -7 | -7 | -7 | -7 | -7 | -7 | -8 | -8 | -9 | -9 | -10 | -10 | -10 | -9 | -9 |
| Change (%) | 3.61 | 1.35 | 2.75 | 6.56 | -0.61 | 2.82 | 0.48 | -0.45 | 2.28 | 1.52 | 2.60 | 6.10 | 8.19 | 8.14 | 8.21 | 1.56 | -3.02 | -6.02 | -10.28 | |
| % of Revenue | -11.36 | -11.24 | -11.31 | -11.16 | -11.51 | -11.59 | -11.87 | -11.81 | -11.64 | -11.90 | -12.05 | -12.18 | -12.86 | -13.87 | -15.56 | -17.38 | -18.26 | -17.81 | -16.69 | -15.07 |
| Net Income | -20 | -15 | -20 | -16 | -16 | -13 | -12 | -19 | -21 | -24 | -26 | -26 | -29 | -28 | -28 | -24 | -22 | -20 | -18 | -15 |
| Change (%) | -24.38 | 32.01 | -21.13 | 1.54 | -19.07 | -8.67 | 57.98 | 12.84 | 10.49 | 9.22 | 1.14 | 9.56 | -3.60 | 1.14 | -13.49 | -8.54 | -10.79 | -8.50 | -16.35 | |
| % of Revenue | -37.85 | -27.32 | -35.80 | -27.11 | -26.65 | -21.86 | -19.88 | -31.11 | -34.74 | -38.39 | -41.79 | -41.67 | -45.41 | -43.65 | -45.81 | -40.91 | -38.70 | -34.71 | -31.68 | -26.66 |
Source: Capital IQ
